Analyses of the skin molecules in patients with severe refractory asthma.
Not Applicable
Recruiting
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000034232
- Lead Sponsor
- Kao Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1.Panelists who have complications such as pneumonitis, infection, and cancer. 2.Panelists who have treated with omarizumab or mepolizumab. 3.Panelists who are regarded as inappropriate in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method